Introduction
The major cause of cognitive deterioration in the elderly is Alzheimer's disease (AD), a disease with complex and heterogeneous pathogenetic mechanisms, involving several genetic and environmental components. It is characterized by progressive synapse and neuronal loss, formation of neuritic plaques and neurofibrillary tangles. Established genetic causes of familial AD involve genes for b-amyloid precursor protein, presenilin-1 and presenilin-2. For the more common sporadic forms of AD, increased risk has been associated with a number of genes, the most important of which is the e allele 4 of apolipoprotein E (ApoE). [1] [2] [3] Inflammation is associated with the degeneration of brain areas and, in AD brains, proinflammatory cytokines and acute phase proteins are overexpressed in microglia and astrocytes surrounding neuropathological lesions. Thus, inflammatory molecules might play an important role in the neurodegeneration associated with AD, and common polymorphisms of genes controlling the high production of these molecules have been shown to be associated with AD. [1] [2] [3] [4] [5] [6] Epidemiological investigations also support the notion that inflammation may play a significant role in AD. In fact, head injuries in early adulthood may be associated with increased risk of AD in late life, 7 and the routine use of nonsteroid antiinflammatory drugs is associated with a decreased incidence of AD. 8 In a recent study, 9 then, whole blood samples from AD and controls were stimulated ex vivo with endotoxin under standard conditions, and the levels of a typical proinflammatory cytokine interleukin(IL-)1b 10 and of the anti-inflammatory cytokine IL-10 11 were assessed. AD patients had a seven-to 10-fold higher production of IL-1b relative to the amount of IL-10, suggesting that an absolute (or relative) reduced production of IL-10 may contribute to the development of AD. 9 Thus, AD patients display a proinflammatory genotype, and the genetic control of inflammation might play a protective role in AD development. Therefore, in the present paper, we have evaluated the role of antiinflammatory cytokine IL-10 in AD. To this purpose, we have analysed the prevalence of three different haplotypes in 132 AD patients and 213 healthy controls, involving three single-nucleotide polymorphisms (SNPs) at À1082 (G-A), À819 (C-T) and À592 (C-A) nucleotides of the IL-10 promoter, associated with different IL-10 production.
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Results
In Table 1 , the genotypic frequencies of AD patients and controls for the three SNPs under study are reported. Concerning the -1082G-A SNP, known to affect the production of IL-10 with a gene dosage related effect, 12 a significant decrease of À1082GG genotype and a significant increase of À1082A/* genotypes were observed in AD patients. This SNP is in linkage with two other SNPs at nt À819 and À592 from the transcription start site of IL-10 gene, [12] [13] [14] [15] [16] displaying in Caucasians the following three putative haplotypes, À1082G/À819C/ À592C (GCC), À1082A/À819C/À592C (ACC), and À1082A/À819T/À592A (ATA). 17, 18 They combine with microsatellite alleles to form haplotypes associated with differential IL-10 production. [12] [13] [14] [15] [16] [19] [20] [21] The evaluation of genotype frequencies of À819C-T and À592C-A SNPs in AD patients when compared to that of healthy controls (Table 1) showed a significant different distribution for both alleles with an increased percentage of individuals carrying À819T/* or À592A/* genotypes. Analysis of haplotype frequencies identified by maximum likelihood analysis in AD patients and healthy controls (Table 2) showed a significant different distribution of the three haplotypes. In particular, a significantly increased frequency of ATA haplotype was found in AD patients.
As expected 22 and already reported, 23 the frequency of the well-known genetic risk factor APOE-e4 allele was significantly increased in AD patients (27 vs 10%; P ¼ 1 Â 10 À8 ). In some studies, the association between AD and cytokine polymorphisms has been shown to be evident (or more evident) in APOE-e4 allele noncarrier patients, suggesting a complex interaction between these genetic factors. 4, 5 As reported in Table 3 , no significant differences in IL-10 allele frequencies were observed between AD ApoE4-positive and -negative subjects. Similar results were obtained by logistic regression performed to evaluate reciprocal interactions among ApoE, IL-10 alleles, gender, and age of onset (data not shown).
Discussion
As previously discussed, a key role in AD brain degeneration is played by chronic inflammation, [1] [2] [3] [4] 7, 8 and the frequency of alleles of proinflammatory cytokine and acute-phase protein genes inducing a high 
*w 2 test was performed to calculate significant different genotype distribution between AD patients and controls. Obtained P-values were corrected for the number of comparisons. A significant increase of -1082A/*, À819T/* and À592A/* genotype carrier percentage was found in AD patients (À1082A/* P=0.018; À819T/* and À592A/* P=0.0007). IL-10 and AD D Lio et al production of these molecules is significantly increased in AD patients. [3] [4] [5] [6] Conversely, the frequency of the socalled allele C of a variable number of tandem repeat polymorphisms, at the 3 0 upstream IL-6 region, associated with a reduction of the production of this proinflammatory cytokine, is significantly decreased in AD patients. 24 Besides, a reduced production of IL-10 has been claimed to be a characteristic of AD patients.
9,25 IL-10 is synthesized in the central nervous system and seems to limit clinical symptoms of several neurological diseases, including AD. In fact, expression of IL-10 is elevated during the course of most major neurological diseases and promotes the survival of neurons and all glial cells in the brain by limiting inflammation. 26, 27 On this basis, we have studied in AD patients the frequency of alleles and haplotypes of IL-10 involved in the low production of this anti-inflammatory cytokine.
The IL-10 gene is located on chromosome 1 at 1q31-32 and is highly polymorphic. 15 Stimulation of human blood samples with bacterial lipopolysaccharide showed large interindividual variations of IL-10 production, suggesting a genetic component of approximately 75%. Interindividual differences in the regulation of IL-10 production may be critical regarding the final outcome of an inflammatory response, that is within physiological limits or a pathological one. 28 Several polymorphisms located close to or within the IL-10 genes are potentially associated with transcription levels; however, the molecular mechanisms linking these polymorphisms to gene expression and post-transcriptional processing are only partially known. Recently, three polymorphisms in the proximal region of IL-10, that might be probable targets for transcription regulating factors, have been described even if conflicting results have been reported on which of these may influence, alone or in reciprocal linkage, the IL-10 transcription. 29, 30 . However, in the proximal promoter region, three well-documented haplotypes, involving three SNPs at À1082 (G-A), À819 (C-T) and À592 (C-A) nucleotides of the IL-10 promoter, have been identified. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] In the presence of allele À1082A, stimulation of lymphocytes with concanavalin A resulted in lower IL-10 production than in allele À1082A-negative cells. 12, 31 The effects of this allelic promoter region difference (relative to the transcription start site) on IL-10 gene activation have been confirmed in reporter gene assays. 13 In the original paper of Turner et al, 12 it was claimed that this correlation was independent of the polymorphisms at positions À819 and À592. However, in further studies the GCC haplotype has been associated with higher and the ATA haplotype with lower production of IL-10 by peripheral blood mononuclear cells than the ACC haplotype. 13 On the other hand, note that inconsistent results have been obtained in the Finnish population. 32 The functional relevance of these polymorphisms has been demonstrated by their involvement in determining susceptibility to immune-inflammatory diseases. A higher À1082G-associated IL-10 production seems to be relevant for autoantibody production in SLE 33 and for the control both of EBV infection and of cutaneous malignant melanoma growing. [34] [35] [36] In the heart recipients, the high IL-10 producer genotype À1082GG apparently protects transplanted hearts. 31 Owing to the pleiotropic functions of IL-10 and to the different structure of the target organ, in kidney transplant recipients, this high IL-10 status is associated with more acute reactions. 31 Conversely, the À1082A allele is implied in diseases characterized by a strong inflammatory response seemingly not controlled by a low IL-10 production linked to this SNP, such as rheumatoid arthritis and inflammatory bowel diseases. [37] [38] [39] Concerning the haplotypes under study, the GCC haplotype is associated with an increased susceptibility to primary Sjogren's syndrome and lupus. 40, 41 On the other hand, the ATA haplotype appears to be positively related to the initial response to interferon-a in chronic hepatitis C, 42 and an increase in the percentage of this haplotype has been demonstrated in relatives and in patients affected by severe juvenile idiopathic arthritis 13, 43 as well as in patients affected by herpes zoster 44 and severe asthma. 45 Interestingly, then, the IL-10 ATA haplotype is associated with neuropsychiatric manifestations in SLE. 46 Data herein reported demonstrate that the percentage of À1082A carrier subjects is significantly increased among AD patients and this increase is mainly due to increase of the ATA haplotype. We were unable to find differences in IL-10 allele distribution among AD patients carrying the E4 allele or not. So, we might conclude that the presence of the À1082A allele and, in particular, of the ATA haplotype may be considered an additive and independent genetic risk factor for AD.
We would like to stress that our study has a number of possible limitations. Since this study was performed with AD patients from Northern Italy, we do not know whether the results are valid in populations of other ethnic origin or not. Another limitation of the study was the lack of data regarding plasma levels of IL-10, but the functional relevance of the studied polymorphisms is well known as discussed above. Thus, we should conclude that our data only suggest that a marker on the 1q32 genomic region may be involved in AD. However, literature data indicate that a proinflammatory genotype contributes to the development of AD. [1] [2] [3] [4] [5] [6] [7] [8] [9] Thus, it is intriguing that the possession of a genotype, associated with a low production of the anti-inflammatory cytokine IL-10, is significantly increased in AD patients. It is noteworthy that the converse À1082GG genotype, associated with an increased production of IL-10, significantly increases the possibility to reach the extreme limit of human lifespan in men. 18 
Materials and methods
Subjects and IL-10 typing DNA samples were obtained from 132 sporadic AD patients (mean onset age 68.9; 46 men and 86 women) and from 213 age-matched healthy controls (132 men and 81 women) from Northern Italy collected during previous studies on the genetic background of AD. [47] [48] [49] [50] Diagnosis of probable AD was performed according to standard clinical procedures and followed the National Institute of Neurological Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association and the Diagnostic and Statistical Manual of Mental Disorders. 51 Written informed consent for enrolling in the study and for personal data management was obtained from healthy controls and relatives of AD patients according to Italian laws. For the IL-10 gene analysis, three different biallelic polymorphisms at IL-10 and AD D Lio et al À1082 (G-A), À819 (C-T) and À592 (C-A) nucleotides were identified using the oligotyping hybridization methodology of Turner et al, 12 as previously described. 52 The allelic ApoE polymorphisms were assessed by the PCR-based method. 53 Statistical analysis IL-10 allele frequencies were evaluated by gene count and haplotype frequencies calculated by a maximum likelihood algorithm (Arlequin Software, University of Geneva). The data were tested for the goodness of fit between the observed and expected genotype values (w 2 test) and their fit to Hardy-Weinberg equilibrium. w 2 tests (3 Â 2 tables either 2 Â 2 table) were performed to calculate significant different genotype (or haplotype) distribution between AD patients and controls. As multiple comparisons were made, Bonferroni's correction was applied, multiplying obtained P-values for six (two alleles for three SNPs). As no significant differences in genotype and haplotype frequencies were observed between men and women both in AD patients and controls, gender was not taken into account further in the presentation of the data. Logistic regression was performed to evaluate reciprocal interactions between ApoE and IL-10 alleles.
